| Literature DB >> 35046782 |
Yee Xing You1, Suzana Shahar1, Mazlyfarina Mohamad2, Nor Fadilah Rajab3, Normah Che Din4, Hui Jin Lau5, Hamzaini Abdul Hamid6.
Abstract
Working memory is developed in one region of the brain called the dorsolateral prefrontal cortex (DLPFC). The dysfunction of this region leads to synaptic neuroplasticity impairment. It has been reported that several biochemical parameters and anthropometric measurements play a vital role in cognition and brain health. This study aimed to investigate the relationships between cognitive function, serum biochemical profile, and anthropometric measurements using DLPFC activation. A cross-sectional study was conducted among 35 older adults (≥60 years) who experienced mild cognitive impairment (MCI). For this purpose, we distributed a comprehensive interview-based questionnaire for collecting sociodemographic information from the participants and conducting cognitive tests. Anthropometric values were measured, and fasting blood specimens were collected. We investigated their brain activation using the task-based functional MRI (fMRI; N-back), specifically in the DLPFC region. Positive relationships were observed between brain-derived neurotrophic factor (BDNF) (β = 0.494, p < 0.01) and Mini-Mental State Examination (MMSE) (β = 0.698, p < 0.01); however, negative relationships were observed between serum triglyceride (β = -0.402, p < 0.05) and serum malondialdehyde (MDA) (β = -0.326, p < 0.05) with right DLPFC activation (R 2 = 0.512) while the participants performed 1-back task after adjustments for age, gender, and years of education. In conclusion, higher serum triglycerides, higher oxidative stress, and lower neurotrophic factor were associated with lower right DLPFC activation among older adults with MCI. A further investigation needs to be carried out to understand the causal-effect mechanisms of the significant parameters and the DLPFC activation so that better intervention strategies can be developed for reducing the risk of irreversible neurodegenerative diseases among older adults with MCI.Entities:
Keywords: anthropometry; biochemical; biomarkers; brain activation; cognitive
Year: 2022 PMID: 35046782 PMCID: PMC8762169 DOI: 10.3389/fnhum.2021.765451
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
FIGURE 10-back and 1-back paradigms.
Demographic characteristics of total participants [expressed in mean ± SD or number (%)].
| Parameters | Total participants ( | Reference range a,b,c,d,e |
| Age (years) | 65.03 ± 3.36 | 69.5 |
| Gender (men, %) | 10 (28.60) | N/A |
| Education (years) | 9.26 ± 4.07 | 5.5 |
| Household income (USD/month) | 402.24 ± 183.43 | 336 |
| Hypertension ( | 15 (42.90) | 37% |
| Type 2 Diabetes Mellitus ( | 6 (17.10) | 41.5% |
| Hyperlipidemia ( | 15 (42.90) | 60.8% |
| Height (cm) | 156.73 ± 7.83 | N/A |
| Weight (kg) | 64.40 ± 10.48 | 62.4 |
| Body mass index (kg/m2) | 26.12 ± 3.01 | 22–27 |
| Waist circumference (cm) | 88.33 ± 8.39 | <90 |
| Systolic blood pressure (mmHg) | 132.91 ± 16.05 | 120 |
| Diastolic blood pressure (mmHg) | 72.63 ± 10.02 | 80 |
| Fasting blood glucose (mmol/L) | 5.46 ± 1.17 | 3.9–5.6 |
| Total cholesterol (mmol/L) | 5.40 ± 0.96 | <5.2 |
| Low density lipoprotein (mmol/L) | 3.27 ± 0.90 | <2.6 |
| High density lipoprotein (mmol/L) | 1.52 ± 0.37 | >1.04 |
| Triglyceride (mmol/L) | 1.38 ± 0.55 | <1.7 |
| Sodium (mmol/L) | 141.51 ± 3.06 | 137–150 |
| Potassium (mmol/L) | 4.45 ± 0.52 | 3.5–5.3 |
| Urea (mmol/L) | 4.34 ± 1.11 | 1.7–8.4 |
| Creatinine (μmol/L) | 69.31 ± 18.16 | 62–115 |
| Uric acid (μmol/L) | 0.35 ± 0.01 | 0.20–0.42 |
| Total protein (g/L) | 72.51 ± 6.20 | 57–82 |
| Albumin (g/L) | 43.91 ± 2.38 | 32–48 |
| Globulin (g/L) | 28.63 ± 6.53 | 20–50 |
| Total bilirubin (μmol/L) | 11.86 ± 4.77 | 3–19 |
| Alkaline phosphatase (U/L) | 74.54 ± 17.11 | 39–117 |
| Alanine aminotransferase (ALT) (U/L) | 20.20 ± 11.19 | 0–40 |
| Aspartate aminotransferase (AST) (U/L) | 22.71 ± 5.43 | 0–40 |
| Inducible nitric oxide synthase (iNOS) (pg/ml) | 182.31 ± 29.21 | N/A |
| Cyclooxygenase-2 (COX-2) (ng/ml) | 1.34 ± 0.70 | N/A |
| Brain-derived neurotrophic factor (BDNF) (pg/ml) | 114.52 ± 53.56 | N/A |
| Malondialdehyde (MDA) (ng/ml) | 211.22 ± 50.27 | N/A |
| Neuropsychological batteries | ||
| MMSE | 25.94 ± 2.18 | 19 |
| Digit Span (Scaled score) | 13.14 ± 1.90 | 7.7 |
| RAVLT immediate recall | 6.83 ± 1.47 | 7 |
| RAVLT delayed recall | 6.11 ± 2.01 | 6 |
| Digit Symbol (Scaled score) | 7.63 ± 2.43 | 8 |
| fMRI behavioral performance | ||
| Reaction accuracy (N-back) (%) | 62.07 ± 10.59 | N/A |
| Reaction time (N-back) (ms) | 2245.95 ± 297.87 | N/A |
| RT/RA index | 37.35 ± 8.87 | N/A |
| fMRI brain activation | ||
| 0-back mean percent signal change (%) Left DLPFC | 0.73 ± 0.52 | N/A |
| 0-back mean percent signal change (%) Right DLPFC | 0.83 ± 0.40 | N/A |
| 1-back mean percent signal change (%) Left DLPFC | 0.82 ± 0.49 | N/A |
| 1-back mean percent signal change (%) Right DLPFC | 0.94 ± 0.40 | N/A |
Activated brain regions during 0-back and 1-back task [p < 0.05, family-wise error (FWE) corrected].
| Anatomical region | L/R | Coordinates | Voxels activated | Maximum | ||
|
|
|
| ||||
|
| ||||||
| Middle frontal gyrus | R | 44 | 10 | 14 | 2,922 | 16.47 |
| L | −34 | 0 | 50 | 2,188 | 14.83 | |
| Precentral gyrus | L | −36 | 4 | 30 | 3 | 10.58 |
| Inferior frontal gyrus | L | −42 | 42 | −2 | 26 | 5.31 |
| Superior frontal gyrus | R | 4 | 40 | 38 | 2 | 4.72 |
|
| ||||||
| Middle frontal gyrus | R | 46 | 12 | 38 | 4,269 | 17.66 |
| L | −40 | 8 | 34 | 3,551 | 16.78 | |
| Superior frontal gyrus | R | 4 | 30 | 38 | 73 | 9.14 |
| L | −6 | 30 | 38 | 18 | 7.73 | |
| Inferior frontal gyrus | R | 50 | 40 | 2 | 2 | 5.89 |
| Precentral gyrus | R | 62 | 6 | 26 | 2 | 4.99 |
L, left; R, right.
FIGURE 2(A) Activated brain region in dorsolateral prefrontal cortex (DLPFC) when performing 0-back task [p < 0.05, family-wise error (FWE) corrected]. (B) Activated brain region in DLPFC when performing 1-back task [p < 0.05, FWE corrected]. rMFG, right middle frontal gyrus; activation intensity: Red to White (low to high).
Relationship between demographic characteristics, anthropometric measurements, biochemical indices, and cognitive tests with dorsolateral prefrontal cortex (DLPFC) activation (n = 35).
| 0-back right DLPFC activation | 0-back left DLPFC activation | 1-back right DLPFC activation | 1-back left DLPFC activation | ||
|
| |||||
|
|
|
|
| ||
| Age | r | –0.118 | –0.031 | −0.340 | –0.020 |
| p | 0.500 | 0.860 | 0.045 | 0.908 | |
| Gender | p | 0.171 | 0.630 | 0.042 | 0.629 |
| Education years | r | 0.131 | 0.107 | 0.400 | 0.119 |
| p | 0.453 | 0.539 | 0.017 | 0.496 | |
| Anthropometric measurements | |||||
| Body mass index | r | –0.226 | –0.264 | –0.166 | –0.413 |
| p | 0.479 | 0.407 | 0.606 | 0.182 | |
| Biochemical profiles | |||||
| Fasting blood glucose | r | –0.304 | –0.010 | –0.047 | –0.190 |
| p | 0.075 | 0.954 | 0.790 | 0.275 | |
| Total cholesterol | r | –0.158 | –0.252 | –0.022 | –0.167 |
| p | 0.365 | 0.144 | 0.900 | 0.337 | |
| Low density lipoprotein | r | –0.166 | –0.263 | –0.121 | –0.097 |
| p | 0.340 | 0.127 | 0.487 | 0.579 | |
| High density lipoprotein | r | 0.111 | 0.163 | 0.431 | 0.187 |
| p | 0.526 | 0.349 | 0.009 | 0.281 | |
| Triglyceride | r | –0.082 | –0.176 | −0.450 | –0.007 |
| p | 0.638 | 0.311 | 0.008 | 0.967 | |
| Biomarkers | |||||
| Inducible nitric oxide synthase | r | –0.300 | –0.281 | –0.258 | –0.156 |
| p | 0.080 | 0.102 | 0.135 | 0.372 | |
| Cyclooxygenase-2 | r | –0.120 | –0.061 | –0.363 | –0.006 |
| p | 0.671 | 0.829 | 0.183 | 0.982 | |
| Brain-derived neurotrophic factor | r | 0.063 | 0.026 | 0.407 | 0.085 |
| p | 0.718 | 0.881 | 0.018 | 0.629 | |
| Malondialdehyde | r | –0.384 | –0.270 | −0.455 | –0.172 |
| p | 0.023 | 0.117 | 0.008 | 0.323 | |
| Neuropsychological batteries | |||||
| Mini-Mental State Examination | r | 0.105 | 0.273 | 0.466 | 0.206 |
| p | 0.548 | 0.112 | 0.005 | 0.236 | |
| Digit Span | r | 0.114 | 0.015 | 0.252 | 0.067 |
| p | 0.516 | 0.933 | 0.144 | 0.704 | |
| RAVLT immediate recall | r | 0.291 | 0.328 | 0.451 | 0.233 |
| p | 0.090 | 0.055 | 0.008 | 0.177 | |
| RAVLT delayed recall | r | 0.243 | 0.136 | 0.105 | 0.093 |
| p | 0.160 | 0.436 | 0.547 | 0.595 | |
| Digit symbol | r | 0.081 | 0.081 | 0.077 | 0.086 |
| p | 0.643 | 0.642 | 0.659 | 0.625 | |
Significant at
Significant at
DLPFC, dorsolateral prefrontal cortex; fMRI, functional MRI; and RAVLT, Rey Auditory Verbal Learning Test.
Multiple linear regression model of biochemical profiles, biomarkers, cognitive tests, and DLPFC activation.
| Parameter | 1-back right DLPFC activation | |||
|
| Adjusted odd ratio (95% CI) |
| ||
| High density lipoprotein | 0.512 | 0.197 (−0.183−0.205) | 0.981 | 0.336 |
| Triglyceride | −0.402 (−0.552 to −0.332) | –2.301 | 0.029 | |
| Brain-derived neurotrophic factor | 0.494 (0.301−0.606) | 2.902 | 0.007 | |
| Malondialdehyde | −0.326 (−0.354 to −0.305) | –2.175 | 0.038 | |
| Mini-Mental State Examination | 0.698 (0.591−0.796) | 3.912 | 0.001 | |
| RAVLT immediate recall | 0.071 (0.059−0.082) | 1.641 | 0.113 | |
Significant at p < 0.05* and p < 0.01** using multiple linear regression (MLR).
MLR model was adjusted by age, gender, and years of formal education.
DLPFC, dorsolateral prefrontal cortex; RAVLT, Rey Auditory Verbal Learning Test.